查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2024544

呼吸道融合細胞病毒診斷市場報告：按產品、最終用途和地區分類（2026-2034 年）

Respiratory Syncytial Virus Diagnostics Market Report by Product, End Use, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3個工作天內

價格

2025年全球呼吸道融合細胞病毒（RSV）診斷市場規模達11.726億美元。展望未來，IMARC Group預測，該市場從2026年到2034年將以7.27%的複合年成長率成長，到2034年達到22.467億美元。

呼吸道融合細胞病毒（RSV）是一種感染肺部和呼吸道的病毒性疾病，可能導致氣喘、住院、肺炎、反覆性行為感染、中耳炎，甚至死亡。診斷可透過血液檢查、胸部X光片、分泌物拭子和脈搏血氧飽和度監測等方法進行，以檢測肺部發炎徵兆、白血球計數和血氧飽和度。 RSV的脈搏血氧計治療方法包括非處方藥、靜脈輸液、濕式氧氣治療、機械通氣和吸入支氣管擴張劑。

呼吸道融合細胞病毒（RSV）診斷市場趨勢

呼吸道合胞病毒（RSV）感染疾病在新生兒期病情可能更為嚴重，因為兩歲以下的嬰兒更容易出現嚴重的呼吸道症狀。這一點，加上家長對兒童保健日益成長的關注，是推動市場成長的關鍵因素。此外，早期診斷後的高存活率和診斷方法的便利性也促進了市場成長。醫療基礎設施的改善以及針對住院嬰兒治療的有利保險報銷政策也推動了市場成長。此外，生物技術和奈米技術等先進技術的出現正在加速RSV尖端檢測系統的開發，包括西方墨點法、酵素免疫分析法試驗（ELISA）、直接螢光和即時聚合酵素鏈鎖反應（PCR）。此外，許多國家的監管機構正在資助用於開發新療法的研發計畫。預計推動市場成長的其他因素包括臨床疫苗測試的增加、體外診斷需求的成長、兒童肺炎發病率的上升以及分子診斷的廣泛應用。

本報告解答的關鍵問題

  • 全球呼吸道融合細胞病毒(RSV) 診斷市場迄今的發展如何？預計未來幾年將如何發展？
  • COVID-19 對全球呼吸道融合細胞病毒(RSV) 診斷市場產生了哪些影響？
  • 主要區域市場有哪些？
  • 按產品分類，市場狀況如何？
  • 依最終用途分類的市場區隔如何？
  • 該產業價值鏈包含哪些不同階段？
  • 該行業的主要促進因素和挑戰是什麼？
  • 全球呼吸道融合細胞病毒（RSV）診斷市場的結構是如何的？主要參與企業有哪些？
  • 該行業的競爭有多激烈？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球呼吸道融合細胞病毒診斷市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 直接螢光測定法（DFA法）
  • 快速抗原診斷測試（RADT）
  • 分子診斷
  • 層析法免疫檢測
  • 影像
  • 凝膠微滴法
  • 流式細胞技術
  • 其他

第7章 市場區隔：依最終用途分類

  • 醫院和診所
  • 研究所
  • 其他

第8章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第9章 SWOT 分析

第10章：價值鏈分析

第11章：波特五力分析

第12章：價格分析

第13章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • bioMerieux SA
    • Bio-Rad Laboratories Inc.
    • Coris BioConcept
    • DiaSorin Molecular LLC（DiaSorin Inc）
    • F. Hoffmann-La Roche AG
    • Merck KGaA
    • Quest Diagnostics Incorporated
    • Quidel Corporation
    • Thermo Fisher Scientific Inc.
Product Code: SR112026A4048

The global respiratory syncytial virus (RSV) diagnostics market size reached USD 1,172.6 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 2,246.7 Million by 2034, exhibiting a growth rate (CAGR) of 7.27% during 2026-2034.

Respiratory syncytial virus (RSV) is a viral infection of the lungs and respiratory tract, which can cause asthma, hospitalization, pneumonia, repeated infections, middle ear infection, and death. It can be diagnosed using blood tests, chest x-rays, a swab of secretions, and pulse oximetry by checking for signs like lung inflammation, white blood cell (WBC) count, and oxygen levels in the blood. Some of the commonly available treatment options for RSV are over-the-counter (OTC) medications, intravenous (IV) fluids, humidified oxygen, mechanical ventilation, and inhaled bronchodilators.

RESPIRATORY SYNCYTIAL VIRUS (RSV) DIAGNOSTICS MARKET TRENDS:

RSV infection can be more serious during the neonatal period as children under two years of age tend to develop severe respiratory symptoms. This, in confluence with the rising focus of parents on child medical care, represents one of the crucial factors fostering the growth of the market. Moreover, the high survival rates after early diagnosis and the easy availability of diagnostic modalities act as other growth-inducing factors. Apart from this, the improving healthcare infrastructure and favorable reimbursement policies for the treatment of hospitalized infants are also contributing to market growth. Furthermore, the advent of advanced techniques like bio- and nanotechnology is facilitating the development of modern detection systems for RSV, such as western blot, enzyme-linked immunosorbent assay (ELISA), direct immunofluorescence, and real-time polymerase chain reaction (PCR). Besides this, governing agencies of numerous countries are funding research and development (R&D) projects for the development of new therapeutics. Other factors projected to drive the market are the growing number of clinical vaccine trials, the escalating demand for in-vitro diagnostics, rising incidences of childhood pneumonia and the increasing adoption of molecular diagnostics.

KEY MARKET SEGMENTATION:

Breakup by Product:

  • Direct Fluorescent Antibody (DFA) Method
  • Rapid Antigen Diagnostic Test (RADTs)
  • Molecular Diagnostics
  • Chromatographic Immunoassay
  • Diagnostic Imaging
  • Gel Microdroplets
  • Flow Cytometry
  • Others

Breakup by End Use:

  • Hospitals and Clinics
  • Laboratory
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

COMPETITIVE LANDSCAPE:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton, Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc., Coris BioConcept, DiaSorin Molecular LLC (DiaSorin Inc), F. Hoffmann-La Roche AG, Merck KGaA, Quest Diagnostics Incorporated, Quidel Corporation and Thermo Fisher Scientific Inc.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How has the global respiratory syncytial virus (RSV) diagnostics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global respiratory syncytial virus (RSV) diagnostics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the end use?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global respiratory syncytial virus (RSV) diagnostics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Direct Fluorescent Antibody (DFA) Method
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Rapid Antigen Diagnostic Test (RADTs)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Molecular Diagnostics
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Chromatographic Immunoassay
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Diagnostic Imaging
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Gel Microdroplets
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Flow Cytometry
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Others
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7 Market Breakup by End Use

  • 7.1 Hospitals and Clinics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Laboratory
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Becton, Dickinson and Company
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 bioMerieux SA
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Bio-Rad Laboratories Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Coris BioConcept
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 DiaSorin Molecular LLC (DiaSorin Inc)
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 F. Hoffmann-La Roche AG
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 SWOT Analysis
    • 13.3.8 Merck KGaA
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Quest Diagnostics Incorporated
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Quidel Corporation
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Thermo Fisher Scientific Inc.
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Respiratory Syncytial Virus Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2020-2025
  • Figure 3: Global: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 4: Global: Respiratory Syncytial Virus Diagnostics Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Respiratory Syncytial Virus Diagnostics Market: Breakup by End Use (in %), 2025
  • Figure 6: Global: Respiratory Syncytial Virus Diagnostics Market: Breakup by Region (in %), 2025
  • Figure 7: Global: Respiratory Syncytial Virus Diagnostics (Direct Fluorescent Antibody-DFA Method) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 8: Global: Respiratory Syncytial Virus Diagnostics (Direct Fluorescent Antibody-DFA Method) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 9: Global: Respiratory Syncytial Virus Diagnostics (Rapid Antigen Diagnostic Test-RADTs) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Respiratory Syncytial Virus Diagnostics (Rapid Antigen Diagnostic Test-RADTs) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Respiratory Syncytial Virus Diagnostics (Molecular Diagnostics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Respiratory Syncytial Virus Diagnostics (Molecular Diagnostics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Respiratory Syncytial Virus Diagnostics (Chromatographic Immunoassay) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Respiratory Syncytial Virus Diagnostics (Chromatographic Immunoassay) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Respiratory Syncytial Virus Diagnostics (Diagnostic Imaging) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Respiratory Syncytial Virus Diagnostics (Diagnostic Imaging) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Respiratory Syncytial Virus Diagnostics (Gel Microdroplets) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Respiratory Syncytial Virus Diagnostics (Gel Microdroplets) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Respiratory Syncytial Virus Diagnostics (Flow Cytometry) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Respiratory Syncytial Virus Diagnostics (Flow Cytometry) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Respiratory Syncytial Virus Diagnostics (Other Products) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Respiratory Syncytial Virus Diagnostics (Other Products) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Respiratory Syncytial Virus Diagnostics (Hospitals and Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Respiratory Syncytial Virus Diagnostics (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Respiratory Syncytial Virus Diagnostics (Laboratory) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Respiratory Syncytial Virus Diagnostics (Laboratory) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Respiratory Syncytial Virus Diagnostics (Other End Uses) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Respiratory Syncytial Virus Diagnostics (Other End Uses) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: North America: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: North America: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: United States: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: United States: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Canada: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Canada: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Asia-Pacific: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Asia-Pacific: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: China: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: China: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Japan: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Japan: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: India: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: India: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: South Korea: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: South Korea: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Australia: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Australia: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Indonesia: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Indonesia: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Others: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Others: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Europe: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Europe: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Germany: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Germany: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: France: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: France: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: United Kingdom: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: United Kingdom: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Italy: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Italy: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Spain: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Spain: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Russia: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Russia: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Others: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Others: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Latin America: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Latin America: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Brazil: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Brazil: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Mexico: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Mexico: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Others: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Others: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Middle East and Africa: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Middle East and Africa: Respiratory Syncytial Virus Diagnostics Market: Breakup by Country (in %), 2025
  • Figure 77: Middle East and Africa: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Global: Respiratory Syncytial Virus Diagnostics Industry: SWOT Analysis
  • Figure 79: Global: Respiratory Syncytial Virus Diagnostics Industry: Value Chain Analysis
  • Figure 80: Global: Respiratory Syncytial Virus Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Respiratory Syncytial Virus Diagnostics Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Respiratory Syncytial Virus Diagnostics Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Respiratory Syncytial Virus Diagnostics Market Forecast: Breakup by End Use (in Million USD), 2026-2034
  • Table 4: Global: Respiratory Syncytial Virus Diagnostics Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 5: Global: Respiratory Syncytial Virus Diagnostics Market: Competitive Structure
  • Table 6: Global: Respiratory Syncytial Virus Diagnostics Market: Key Players